Raloxifene through its Cannabinoid Type-2 Receptor Inverse Agonism Mitigates Visual Deficits and Pathology after Mild TBI
Publication/Presentation Date
7-2019
Volume
60
Issue
9
Published In/Presented At
ARVO Annual Meeting Abstract
Disciplines
Medicine and Health Sciences
Department(s)
Department of Surgery
Document Type
Article
COinS